Victory Capital Management Inc Eiger Bio Pharmaceuticals, Inc. Transaction History

Victory Capital Management Inc

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2020 Aug 07, 2020	SELL	$5.4 - $13.37 $19,704 - $48,787	-3,649 Closed	0 $0
Q1 2020 May 04, 2020	SELL	$4.91 - $14.7 $17,538 - $52,508	-3,572 Reduced 49.47%	3,649 $25,000
Q4 2019 Feb 06, 2020	BUY	$9.77 - $15.66 $34,077 - $54,622	3,488 Added 93.44%	7,221 $108,000
Q4 2019 Feb 04, 2020	SELL	$9.77 - $15.66 $2,403 - $3,852	-246 Reduced 6.18%	3,733 $46,000
Q3 2019 Nov 12, 2019	BUY	$9.59 - $12.0 $38,158 - $47,748	3,979 New	3,979 $41,000

748K

Ticker EIGR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 43,966,800
Market Cap $496M
Description
Eiger BioPharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on the development and commercialization of targeted therapies for rare and ultra-rare diseases in the United States and internationally. Its lead product candidate is Lonafarnib, an orally bioavailable, small molecule, which is in Phase III clinical trials to ...

Get notified when there are updates to the investment portfolio of Victory Capital Management Inc, based on Form 13F filings with the SEC.

Stay updated on Victory Capital Management Inc with notifications on news.